Sampre Nutritions has signed a three-year manufacturing and supply agreement with Reliance Consumer Products Limited to produce confectionery, nutraceutical, and food items. The deal, valued at ₹12–15 crore annually, is expected to strengthen Sampre’s revenue streams and expand its footprint in consumer nutrition and packaged food manufacturing.
Sampre Nutritions Limited has entered into a manufacturing agreement with Reliance Consumer Products Limited (RCPL), a subsidiary of Reliance Retail, marking a significant business partnership in India’s fast-growing food and nutraceutical segment. Signed on October 8, 2025, the three-year contract covers manufacturing, packaging, and supply of confectionery products and nutraceutical lines for RCPL, aligning with its quality and specification standards.
The deal is projected to generate ₹12–15 crore in annual business, providing a major boost to Sampre Nutritions’ operational scale and product diversification strategy. With this partnership, the Hyderabad-based company aims to leverage its existing manufacturing capabilities to meet RCPL’s expanding product portfolio in the consumer food and nutrition market.
According to disclosures, the agreement is not a related-party transaction, and RCPL does not hold any equity stake in Sampre Nutritions. The commercial relationship is structured on a standard business model where Sampre will retain ownership and risk in the goods until acceptance by RCPL upon delivery. Pricing and payment terms will be governed by predefined mechanisms within the contract.
Key highlights
- Agreement signed on October 8, 2025, between Sampre Nutritions and Reliance Consumer Products Limited.
- Sampre will manufacture, pack, and supply confectionery and nutraceutical products such as lollipops, toffees, and health supplements.
- Expected to generate ₹12–15 crore in annual business over a tenure of three years.
- Scope covers nutraceuticals, food, and hard-boiled confectionery products meeting RCPL’s standards.
- RCPL to fix pricing as per contractually agreed mechanisms.
- Not a related-party transaction; no equity linkage between the two companies.
- No issuance of shares or board-level representation involved in the deal.
- Sampre to disclose updates in case of amendments or termination of the agreement in future.
This collaboration underscores RCPL’s strategy to scale its FMCG footprint through manufacturing partnerships while enabling Sampre Nutritions to strengthen its industry positioning and diversify its client base. The agreement highlights a growing trend of strategic alliances between established consumer giants and specialized manufacturing firms to harness India’s rising consumption demand.
Sources: BSE Corporate Filings, Sampre Nutritions Ltd Exchange Announcement